Related Experiment Video
Updated: Oct 12, 2025
06:26
Analysis of Side Population in Solid Tumor Cell Lines
Published on: February 23, 2021
4.5K
Side population analysis in clear cell renal cell carcinoma
Richard Huang1, Jalna Meens2, Scott Yuzwa1
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5G 1M1, Canada.
Biochemical and Biophysical Research Communications
|November 23, 2021
Summary
Researchers investigated cancer stem cells in clear cell renal cell carcinoma (ccRCC). The side population method, often used for cancer stem cell discovery, was found insufficient for identifying these cells in ccRCC.
Area of Science:
- Oncology
- Stem Cell Biology
- Cancer Research
Background:
- Cancer stem cells (CSCs) play a crucial role in tumor development and progression.
- While CSC identity is established in hematological cancers, it remains unclear in many solid tumors.
- Clear cell renal cell carcinoma (ccRCC) is the predominant kidney cancer subtype, yet its CSCs are not well-defined.
Purpose of the Study:
- To investigate the existence and identity of cancer stem cells in clear cell renal cell carcinoma (ccRCC).
- To evaluate the efficacy of the side population (SP) method for identifying ccRCC stem cells.
Main Methods:
- Utilized the side population (SP) approach in ccRCC cell lines.
- Performed cell-based assays to assess stem-like properties.
- Conducted limiting dilution assays to compare tumor-initiating potential.
- Employed single-cell RNA-sequencing to analyze cellular heterogeneity.
Main Results:
- A distinct side population (SP) was identified in all tested ccRCC cell lines.
- SP cells exhibited characteristics suggestive of stem-like properties in initial assays.
- Limiting dilution assays showed similar tumor-initiating capacities between SP and non-SP cells.
- Single-cell RNA-sequencing revealed minimal molecular differences between SP and non-SP populations.
Conclusions:
- The side population (SP) method is not adequate for discovering cancer stem cells in clear cell renal cell carcinoma (ccRCC).
- Further research is needed to identify reliable markers and methods for ccRCC stem cell characterization.
